🕵️ Structure Therapeutics Inc. ($GPCR)
SEC insider & ownership activity, last 12 months · CIK 1888886 · every row links its SEC filing
Over the last 12 months insiders sold $8.3M with no open-market buying against it. FMR LLC sold $7.5M (Jul–Jul). Janus Henderson Group PLC trimmed 8.0% → 7.7%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $8.3M (26 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| FMR LLC | 0 | – | 23 | $7.5M | Jul 22, 2026 |
| Xichen Lin | 0 | – | 3 | $788K | Jul 14, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 15.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 15.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Wellington Management Group LLP | 10.1% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Group Holdings LLP | 10.1% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Investment Advisors Holdings LLP | 10.1% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Management Company LLP | 9.6% | 13G | Feb 10, 2026 | filing ↗ | |
| Avoro Capital Advisors LLC | 9.4% | 13G | Nov 14, 2025 | filing ↗ | |
| Aghazadeh Behzad | 9.4% | 13G | Nov 14, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 7.7% | 13G | Nov 14, 2025 | filing ↗ | |
| DEEP Track Capital, LP | 6.0% | 13G | Feb 13, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 6.0% | 13G | Feb 13, 2026 | filing ↗ | |
| David Kroin | 6.0% | 13G | Feb 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Xichen Lin | $1.7M | Jun 25, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Other events (8.01) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 30, 2025 | filing ↗ |
| Other events (8.01) | Dec 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing ↗ |